RAYDIANT OXIMETRY

In a bid to provide healthcare professionals with a more accurate method to to evaluate fetal oxygenation, Raydiant Oximetry is developing Lumerah™, a noninvasive fetal pulse oximeter... Raydiant Oximetry, a Fogarty Institute company that is developing an innovative fetal monitor to improve outcomes for mothers and babies during childbirth, has closed a $5.6 million Series A funding round led by VCapital... Raydiant Oximetry's innovative photonic sensor technology helps keep mothers and babies safe during childbirth. In developing Lumerah™, a non-invasive sensor technology that directly measures fetal oxygen levels, Raydiant Oximetry aims to profoundly reduce the rising mortality and morbidity rates among mothers and babies during childbirth. Offering obstetric providers an innovative new monitoring technique, we will not only reduce childbirth mortality rates but the number of unnecessary C-sections.

Also known as: Raydiant Oximetry, Inc.

Primary location: San Ramon United States